OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines

doi:10.1186/1742-4690-6-S3-O13

Retrovirology

Volume 6
Suppl 3

Viewing options:

Abstract
Full text
PDF (133KB)

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
Other articles by authors
on Google Scholar

Jacobs B
Kibler K
Wong S
Huynh T
Holechek S
Denzler K
Arndt W
Parrington M
Tartaglia J
Pantaleo G

on PubMed

Jacobs B
Kibler K
Wong S
Huynh T
Holechek S
Denzler K
Arndt W
Parrington M
Tartaglia J
Pantaleo G
Related articles/pages
on Google

on Google Scholar

Tools:

Post to:

This article is part of the supplement: AIDS Vaccine 2009 .

Oral presentation

OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines

B Jacobs¹, K Kibler¹, S Wong¹, T Huynh¹, S Holechek¹, K Denzler¹, W Arndt¹, M Parrington², J Tartaglia² and G Pantaleo³

¹The Biodesign Institute, CIDV, Arizona State University, Tempe, AZ, USA

²Sanofi-Pasteur, Toronto, Canada

³CHUV, Lausanne, Switzerland

corresponding author email

from AIDS Vaccine 2009
Paris, France. 19–22 October 2009

Retrovirology 2009, 6(Suppl 3):O13doi:10.1186/1742-4690-6-S3-O13


Published:	22 October 2009

First paragraph (this article has no abstract)

Poxvirus viruses have been utilized for many years as vaccine vectors. Recent years have seen an increase in efforts to identify safer pox vectors to express heterologous antigens, in this case HIV antigens.